Latest tumor Stories
Completion of Enrollment Expected in 2015; Progression-Free Survival Data Expected in mid-2016 LOS ANGELES, Sept.
- Awarded phase II STTR grant of approximately $1.1 million from NIH to develop tumor activated prodrugs BOSTON, Sept.
ALBANY, New York, September 29, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Circulating Circulating Tumor Cells (CTCs)
Additional Study Focuses on the Detection and Quantitative Monitoring of EGFR Mutations in Lung Cancer Patients SAN DIEGO, Sept.
Medical journey of Arizona boy precedes that of Britain's Ashya King SAN DIEGO, Sept.
LOS ANGELES, Sept.
-- PEG-Irinotecan is a novel, long-acting polymer-drug conjugate which inhibits Topo-I associated with solid tumors SHENYANG, China, Sept.
REDWOOD CITY, Calif., Sept.
Unusually broad range of tumors treated, other benefits seen in first seven months SAN FRANCISCO, Sept.
A study led by University of Colorado Cancer Center published today in the journal Nature uses a novel approach to target the activation of a protein that drives some cancers. AURORA,
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.